Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients
Objectives To evaluate the effectiveness and safety of upadacitinib in treatment-refractory inflammatory myositis.Methods Patients with refractory inflammatory myositis treated with upadacitinib from a single urban centre in Vancouver, British Columbia, Canada, were included from September 2020 to J...
Saved in:
| Main Authors: | Kun Huang, Jan Dutz, Madelaine Beckett |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-02-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/10/1/e003837.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: Upadacitinib in the management of refractory urticarial vasculitis
by: Maan M. Almaghrabi, et al.
Published: (2025-08-01) -
Upadacitinib in refractory cutaneous pseudolymphoma: A case report
by: Elisabetta Danese, et al.
Published: (2025-06-01) -
Upadacitinib in daily practice for refractory atopic dermatitis in adolescents: a case series of the BioDay registry
by: Florence Vroman, et al.
Published: (2025-12-01) -
Advanced Combination Therapy with Biologics and Upadacitinib in Refractory Inflammatory Bowel Disease: A Retrospective Study from Taiwan
by: Meng MJ, et al.
Published: (2025-02-01) -
Case Report: Successful management of refractory palmoplantar pustulosis with upadacitinib
by: Boyun Yang, et al.
Published: (2025-03-01)